SCH42495 (racemate) is an orally active neutral endopeptidase (NEP) inhibitor with antihypertensive activity; it serves as an oral prodrug of SCH42354. It selectively inhibits the hydrolysis of leu-enkephalin and atrial natriuretic factor (ANF) in vitro (IC50 of 8.3 and 10.0 nM, respectively). In vivo, it significantly reduces pulmonary vascular remodeling and ventricular hypertrophy in hypoxic rats, attenuates cardiovascular remodeling secondary to chronic hypoxia, and produces dose-dependent reductions in blood pressure in DOCA-Na hypertensive rats.